FGF1 and breast carcinoma: FGF1 treatment increases the basal ECAR in breast cancer cell lines (Castillo-Castrejon et al., 2023), while FGF2 treatment increases lactate production in murine adipocytes (Kihira et al., 2011), rat Sertoli cells (Riera et al., 2002), and human squamous cell carcinoma cells (Fumarola et al., 2017).